Latest developments in neuroscience R&D
Super Session 2 – Neurosciences
Neuroscience has not only proven to be one of the most challenges areas for finding treatments, it is also one of the diseases putting the greatest burden on society. Current treatment will only temporarily improve symptoms but are there new treatments around the corner potentially stopping or significantly delaying the progression of the disease? International experts will share their views on what is possible based on the knowledge currently available.
Moderator(s): Ms. Ingrid Heath - Partner, Adlersson & Heath
Dr. Jina Elise Swartz - Global Clinical Development, MSD Dr. Per-Ola Freskgård - CSO, BioArctic Dr. Steffen Thirstrup - Director, NDA Regulatory Advisory Board Dr. Göran Gustafsson - Department Head, Printed Electronics, Biocom Lab/RISE Dr. Patrick Sobocki - Investment Manager, Industrifonden